首页> 外国专利> Predicting prostate cancer recurrence in pre-treatment prostate magnetic resonance imaging (MRI) with combined tumor induced organ distension and tumor radiomics

Predicting prostate cancer recurrence in pre-treatment prostate magnetic resonance imaging (MRI) with combined tumor induced organ distension and tumor radiomics

机译:结合肿瘤诱导的器官扩张和肿瘤放射学的治疗前前列腺磁共振成像(MRI)预测前列腺癌的复发

摘要

Embodiments predict prostate cancer (PCa) biochemical recurrence (BCR) employing an image acquisition circuit that accesses a first pre-treatment image and a second pre-treatment image of a region of tissue demonstrating PCa, a distension feature circuit that extracts a set of distension features from the first pre-treatment image, and computes a first probability of PCa BCR based on the set of distension features, a radiomics circuit that extracts a set of radiomics features from the second pre-treatment image, and computes a second probability of PCa recurrence based on the set of radiomics feature, a combined tumor induced organ distension with tumor radiomics (COnTRa) circuit that computes a joint probability that the region of tissue will experience PCa BCR based on the first probability and the second probability, and a display circuit that displays the joint probability.
机译:实施例使用图像获取电路来预测前列腺癌(PCa)生化复发(BCR),该图像获取电路访问展示了PCa的组织区域的第一预处理图像和第二预处理图像,该收缩特征电路提取一组扩张从第一预处理图像中提取特征,并基于该扩张特征集计算PCa BCR的第一概率,放射线电路从第二预处理图像中提取一组放射特征,并计算PCa的第二概率基于放射线特征集的复发,结合肿瘤诱发的器官扩张和肿瘤放射线(COnTRa)电路,该电路根据第一概率和第二概率计算组织区域将经历PCa BCR的联合概率,以及显示电路显示联合概率。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号